Related references
Note: Only part of the references are listed.The NK-1 Receptor: A New Target in Cancer Therapy
Miguel Munoz et al.
CURRENT DRUG TARGETS (2011)
Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
Giovanni Germano et al.
CANCER RESEARCH (2010)
Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
Dan Huang et al.
CANCER RESEARCH (2010)
Differences underlying EGFR and HER2 oncogene addiction
Anthony C. Faber et al.
CELL CYCLE (2010)
Antitumor Activity of Targeting Src Kinases in Endothelial and Myeloid Cell Compartments of the Tumor Microenvironment
Wei Liang et al.
CLINICAL CANCER RESEARCH (2010)
Tyrosine Kinase Receptor Transactivation Associated to G Protein-Coupled Receptors
Vanessa Almendro et al.
CURRENT DRUG TARGETS (2010)
Neurokinin-1 receptor antagonists: a comprehensive patent survey
Shih-Chung Huang et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
Li Liu et al.
CANCER RESEARCH (2009)
Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells
Todd W. Miller et al.
CLINICAL CANCER RESEARCH (2009)
A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas
Toshimasa Akazawa et al.
JOURNAL OF NEUROCHEMISTRY (2009)
The Role of MMP7 and Its Cross-Talk with the FAS/FASL System during the Acquisition of Chemoresistance to Oxaliplatin
Vanessa Almendro et al.
PLOS ONE (2009)
The NK-1 Receptor Is Expressed in Human Primary Gastric and Colon Adenocarcinomas and Is Involved in the Antitumor Action of L-733,060 and the Mitogenic Action of Substance P on Human Gastrointestinal Cancer Cell Lines
Marisa Rosso et al.
TUMOR BIOLOGY (2008)
Oncogenic and metastatic properties of preprotachykinin-I and neurokinin-1 genes
Arun S. Singh et al.
VASCULAR PHARMACOLOGY (2006)
Tachykinin receptors antagonists: From research to clinic
Laura Quartara et al.
CURRENT DRUG TARGETS (2006)
Tachykinins and their receptors in human malignancies
Carla Palma
CURRENT DRUG TARGETS (2006)
Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists
T Hoffmann et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells
GE Konecny et al.
CANCER RESEARCH (2006)
The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential
Tammy A. Castro et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides
HJ Patel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27(Kip1) via multiple signaling pathways
XF Le et al.
CELL CYCLE (2005)
Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal compartment of the bone marrow: A model of early cancer progression
G Rao et al.
CANCER RESEARCH (2004)
Tachykinin-mediated modulation of the immune response
KL Bost
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E
DC Fingar et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Antitumoral action of the neurokinin-1 receptor antagonist L-733060 on human melanoma cell lines
M Muñoz et al.
MELANOMA RESEARCH (2004)
Metalloproteinases and transforming growth factor-α mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes
HW Koon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer
H Friess et al.
LABORATORY INVESTIGATION (2003)
Medicinal chemistry of selective neurokinin-1 antagonists
JM Humphrey
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2003)
The tachykinin peptide family
C Severini et al.
PHARMACOLOGICAL REVIEWS (2002)
Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study
DD Joshi et al.
BLOOD (2001)
Epidermal growth factor receptor transactivation mediates substance P-induced mitogenic responses in U-373 MG cells
I Castagliuolo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Increased expression of preprotachykinin-1 and neurokinin receptors in human breast cancer cells:: Implications for bone marrow metastasis
D Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
